Retatrutide
Dosed helps you track Retatrutide protocols with weekly scheduling and dose titration tracking. Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors — representing the next generation of metabolic research compounds.
Protocol Information
⏰Typical Schedule
Once weekly (subcutaneous injection)
📊Half-Life
Approximately 6 days
The ~6 day half-life supports once-weekly dosing similar to semaglutide. Dosed uses this for half-life curve calculations.
🧪Reconstitution
Research forms require reconstitution with bacteriostatic water. Use Dosed's reconstitution calculator for precise concentration and volume calculations.
Calculator available in Dosed
📍Injection Sites
Abdomen (subcutaneous), Thigh (subcutaneous), Upper arm (subcutaneous)
Rotate injection sites weekly to promote consistent absorption and reduce site reactions.
Tracking Features in Dosed
- ✓Weekly dose scheduling with reminders
- ✓Dose titration tracking through escalation phases
- ✓Injection site rotation with visual body map
- ✓Protocol history and adherence monitoring
- ✓Notes for documenting research observations
App Features for Retatrutide
Set preferred injection day with advance reminders.
Log dose escalations through titration phases.
Visual body map for subcutaneous injection site tracking.
Complete dose history exportable for research documentation.
Research References
- PMID: 37351564- Phase 2 trial of retatrutide for obesity
Track Your Retatrutide Protocol
Download Dosed to track your Retatrutide protocol with reminders, injection site rotation, and comprehensive history.
Download DosedFAQs about Retatrutide Tracking
Common questions about tracking this protocol
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors, while semaglutide targets only GLP-1. This triple mechanism is being studied for potentially enhanced metabolic effects.
No. Retatrutide is an investigational compound currently in Phase 3 clinical trials. It is not approved for any therapeutic use. Track research protocols only.
Dosed supports weekly scheduling with day-of-week selection, advance reminders, injection site rotation, and dose logging. The half-life calculator shows compound levels between weekly doses.
Important Disclaimer
Retatrutide is an investigational compound currently in clinical trials. It is NOT approved by the FDA for any use. This information is for research and educational purposes only. Dosed is a tracking tool and does not provide medical advice.